在被非活化COVID-19疫苗接种后患有膜性病患者的复发风险

Hanzhen Zhang1, Ruiying Chen2, Mingyue Xu2

  • 1Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China, 15301050144@fudan.edu.cn.

Nephron
|April 2, 2025
PubMed
概括

失活的COVID-19疫苗接种并没有增加患有膜性病的患者复发或恶化的风险. 这项研究在接种疫苗和未接种疫苗的人群中发现了类似的结果,这表明疫苗对这个患者群体的安全性.

相关概念视频

Vaccinations01:51

Vaccinations

Overview
43.1K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
473
Cross-reactivity00:42

Cross-reactivity

Overview
30.9K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202